Frontiers | Intranasal Vaccination With Recombinant Antigen-FLIPr ...

Frontiers | Intranasal Vaccination With Recombinant Antigen-FLIPr ...

Frontiers | Intranasal Vaccination With Recombinant Antigen-FLIPr ...

Frontiers | Corrigendum: Recent Progress in Recombinant Influenza ...

Frontiers | An intranasal vaccine targeting the receptor binding domain ...

Frontiers | A nasal vaccine with inactivated whole-virion elicits ...

Frontiers | An intranasal stringent response vaccine targeting ...

Frontiers | Trivalent mRNA vaccine-candidate against seasonal flu with ...

Frontiers | Intranasal trivalent candidate vaccine elicits broad ...

Frontiers | Mucosal Immunity and Protective Efficacy of Intranasal ...

Frontiers | Nanotechnology-driven advances in intranasal vaccine ...

Frontiers | Mucosal Immunity and Protective Efficacy of Intranasal ...

Frontiers | Trivalent mRNA vaccine-candidate against seasonal flu with ...

Frontiers | Mucosal Immunity and Protective Efficacy of Intranasal ...

Frontiers | Nanotechnology-driven advances in intranasal vaccine ...

Frontiers | A nasal vaccine with inactivated whole-virion elicits ...

Frontiers | A nasal vaccine with inactivated whole-virion elicits ...

Frontiers | Trivalent mRNA vaccine-candidate against seasonal flu with ...

Frontiers | Trivalent mRNA vaccine-candidate against seasonal flu with ...

Intranasal immunization with recombinant Vaccinia virus encoding ...

Intranasal immunization with recombinant Vaccinia virus encoding ...

Frontiers | Editorial: Novel approaches for developing vaccines against ...

Frontiers | An ambient-temperature stable nanoparticle-based vaccine ...

Frontiers | Increased efficacy of influenza virus vaccine candidate ...

Intranasal Administration of Recombinant Influenza Vaccines in Chimeric ...

Frontiers | Breakthrough infection evokes the nasopharyngeal innate ...

Intranasal Immunization with Nasal Immuno-Inducible Sequence-Fused ...

Frontiers | Development of an intranasal, universal influenza vaccine ...

Intranasal Immunization with a Formalin-Inactivated Human Influenza A ...

Frontiers | Reprogramming viral immune evasion for a rational design of ...

Intranasal Immunization with Nasal Immuno-Inducible Sequence-Fused ...

Intranasal Immunization with a Formalin-Inactivated Human Influenza A ...

Intranasal Administration of Recombinant Influenza Vaccines in Chimeric ...

Intranasal Administration of Recombinant Influenza Vaccines in Chimeric ...

Frontiers | Development of an intranasal, universal influenza vaccine ...

Intranasal recombinant protein subunit vaccine targeting TLR3 induces ...

Frontiers | Increased efficacy of influenza virus vaccine candidate ...

Intranasal recombinant protein subunit vaccine targeting TLR3 induces ...

Intranasal vaccination induced cross-protective secretory IgA ...

Intranasal Prime–Boost with Spike Vectors Generates Antibody and T-Cell ...

Intranasal DNA Vaccination Induces Potent Mucosal and Systemic Immune ...

The protective effect of intranasal immunization with inactivated ...

Novel intranasal vaccine technology shows promise for broad protection ...

Working together: a multi-component intranasal vaccine provides ...

Frontiers | Prospects for RNAi Therapy of COVID-19

Novel intranasal vaccine technology shows promise for broad protection ...

Intranasal administration of octavalent next-generation influenza ...

Intranasal Vaccine Boosts Protection Against Bird Flu - European ...

Intranasal administration of octavalent next-generation influenza ...

Frontiers | Influenza Viruses: Innate Immunity and mRNA Vaccines

Intranasal Single-Replication Influenza Vector Induces Cross-Reactive ...

Vaccines | Special Issue : The Future of Influenza Virus Vaccines ...

Intranasal Single-Replication Influenza Vector Induces Cross-Reactive ...

Development of an Intranasal Gel for the Delivery of a Broadly Acting ...

Evaluating the Immunogenicity of an Intranasal Microparticle ...

Nasal prevention of SARS-CoV-2 infection by intranasal influenza-based ...

Intranasal DNA Vaccine for Protection against Respiratory Infectious ...

Intranasal DNA Vaccine for Protection against Respiratory Infectious ...

Nasal prevention of SARS-CoV-2 infection by intranasal influenza-based ...

Nasal prevention of SARS-CoV-2 infection by intranasal influenza-based ...

Intranasal Single-Replication Influenza Vector Induces Cross-Reactive ...

Nanoplatform Based Intranasal Vaccines: Current Progress and Clinical ...

Nasal prevention of SARS-CoV-2 infection by intranasal influenza-based ...

Nanoplatform Based Intranasal Vaccines: Current Progress and Clinical ...

Intranasal Single-Replication Influenza Vector Induces Cross-Reactive ...

Intranasal delivery of NS1-deleted influenza virus vectored COVID-19 ...

Nasal prevention of SARS-CoV-2 infection by intranasal influenza-based ...

Intranasal Single-Replication Influenza Vector Induces Cross-Reactive ...

Intranasal DNA Vaccine for Protection against Respiratory Infectious ...

Evaluating the Immunogenicity of an Intranasal Microparticle ...

Advances in intranasal vaccine delivery: A promising non-invasive route ...

A nasal vaccine with inactivated whole-virion elicits protective ...

Octavalent intranasal flu vaccine proves effective in neutralizing both ...

Targeting Respiratory Viruses: The Efficacy of Intranasal mRNA ...

Influenza Vaccine With Consensus Internal Antigens as Immunogens ...

Targeting Respiratory Viruses: The Efficacy of Intranasal mRNA ...

Nasal vaccination against SARS-CoV-2: Synergistic or alternative to ...

Could intranasal SARS-CoV-2 vaccines be a practical alternative to ...

An intranasal combination vaccine induces systemic and mucosal immunity ...

Nasal vaccination against SARS-CoV-2: Synergistic or alternative to ...

Intranasal pediatric parainfluenza virus-vectored SARS-CoV-2 vaccine is ...

Intranasal COVID-19 vaccines: From bench to bed - eBioMedicine

Intranasal COVID-19 vaccines: From bench to bed - eBioMedicine

Development of an Influenza/COVID-19 Combination mRNA Vaccine ...

Recombinant influenza vaccines. - Abstract - Europe PMC

Safety and immunogenicity of a live-attenuated influenza virus vector ...

mRNA, the beginning of a new influenza vaccine game. - Abstract ...

Design and Characterization of a New Formulation for the Delivery of ...

Development of an Influenza/COVID-19 Combination mRNA Vaccine ...

Amplifying RNA Vaccine Development | New England Journal of Medicine

The Design and Prospects of Influenza Virus Vaccines Based on Conserved ...

Interferon antagonist proteins of influenza and vaccinia viruses are ...

Advantages of Broad-Spectrum Influenza mRNA Vaccines and Their Impact ...

Selective incorporation of influenza virus RNA segments into virions | PNAS

Needle-free influenza vaccination - The Lancet Infectious Diseases

Design and Characterization of a New Formulation for the Delivery of ...

Development of an Influenza/COVID-19 Combination mRNA Vaccine ...

Construction and Immunogenicity of Modified mRNA-Vaccine Variants ...

A Nasal Vaccine Candidate, Containing Three Antigenic Regions from SARS ...

Design and immunological evaluation of two-component protein ...

A Nasal Vaccine Candidate, Containing Three Antigenic Regions from SARS ...

A Nasal Vaccine Candidate, Containing Three Antigenic Regions from SARS ...

Intranasal COVID-19 vaccines: From bench to bed - eBioMedicine

Intranasal COVID-19 vaccines: Is it a boon or bane? - Abstract - Europe PMC

Scientists Develop Game-Changing Needle-Free COVID-19 Intranasal Vaccine

Construction and evaluation of a self-replicative RNA vaccine against ...

Antigen modifications improve nucleoside-modified mRNA-based influenza ...

Polymer formulated self-amplifying RNA vaccine is partially protective ...

Intranasal vaccine shows promise against COVID variants in hamsters

Replicon RNA vaccines: design, delivery, and immunogenicity in ...

Nasal Vaccines and the Future of Immunization

Advanced Vaccine Design Strategies against SARS-CoV-2 and Emerging Variants

Universal Flu mRNA Vaccine: Promises, Prospects, and Problems

Preventing Influenza: New Opportunities for an Old Disease

Novel Approaches for The Development of Live Attenuated Influenza Vaccines

Cellular and Molecular Immunity to Influenza Viruses and Vaccines

Reverse Genetics Approaches for the Development of Influenza Vaccines

An innovative nasal vaccine strategy to combat COVID

A nasal COVID vaccine using a weakened influenza vector

Development of Nasal Vaccines and the Associated Challenges - PMC

Covid Nasal Vaccines Get A Boost - by Eric Topol